313 related articles for article (PubMed ID: 28108128)
1. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
2. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
Hale SL; Herring MJ; Kloner RA
J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
[TBL] [Abstract][Full Text] [Related]
3. Rapid Induction of Hypothermia by the ThermoSuit System Profoundly Reduces Infarct Size and Anatomic Zone of No Reflow Following Ischemia-Reperfusion in Rabbit and Rat Hearts.
Herring MJ; Dai W; Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):193-202. PubMed ID: 24906542
[TBL] [Abstract][Full Text] [Related]
4. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
[TBL] [Abstract][Full Text] [Related]
5. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
6. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
[TBL] [Abstract][Full Text] [Related]
7. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.
Hale SL; Dae MW; Kloner RA
Cardiovasc Res; 2003 Sep; 59(3):715-22. PubMed ID: 14499873
[TBL] [Abstract][Full Text] [Related]
8. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
9. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion.
Hale SL; Kloner RA
J Thromb Thrombolysis; 2015 Jan; 39(1):50-4. PubMed ID: 25017632
[TBL] [Abstract][Full Text] [Related]
11. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
[TBL] [Abstract][Full Text] [Related]
12. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
14. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion.
Reffelmann T; Hale SL; Dow JS; Kloner RA
Circulation; 2003 Dec; 108(23):2911-7. PubMed ID: 14656914
[TBL] [Abstract][Full Text] [Related]
15. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
[TBL] [Abstract][Full Text] [Related]
16. Myocardial hypothermia induced after reperfusion does not prevent adverse left ventricular remodeling nor improve cardiac function.
Shi J; Dai W; Carreno J; Hale SL; Kloner RA; Kay GL
Life Sci; 2019 Jul; 229():98-103. PubMed ID: 30991060
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
[TBL] [Abstract][Full Text] [Related]
18. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction?
Miki T; Liu GS; Cohen MV; Downey JM
Basic Res Cardiol; 1998 Oct; 93(5):372-83. PubMed ID: 9833149
[TBL] [Abstract][Full Text] [Related]
19. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
[TBL] [Abstract][Full Text] [Related]
20. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
